by Akanksha Bakshi | Feb 23, 2026 | General
Wall Street sentiment toward General Mills Inc. (NYSE:GIS) is becoming cautious. A leading analyst has downgraded the stock, reduced his price target and extended the expected recovery timeline. Several others share this outlook. • What are GIS shares doing today?...
by Evette Mitkov | Feb 23, 2026 | General
Moderna Inc (NASDAQ:MRNA) shares are trading higher on Monday. Piper Sandler boosted its price target on the stock to $69 from $63 while reiterating an Overweight rating. Here’s what you should know. Moderna shares are trending higher. Why is MRNA stock advancing?...
by Henry Khederian | Feb 23, 2026 | General
Palantir Technologies Inc (NASDAQ:PLTR) shares are trading lower Monday afternoon, extending February’s slide as investors reassessed how rapid advances in AI-driven cybersecurity could reshape demand for the company’s software. Here’s what investors need to...
by Lekha Gupta | Feb 23, 2026 | General
Dominion Energy Inc. (NYSE:D) on Monday reported fourth-quarter 2025 results that beat Wall Street estimates on both earnings and revenue and raised its five-year capital spending plan by about $15 billion to support surging data center demand. Earnings Snapshot The...
by Vandana Singh | Feb 23, 2026 | General
ImmunityBio Inc. (NASDAQ:IBRX) shares are up on Monday following the company’s announcement of significant revenue growth. • ImmunityBio stock is challenging resistance. Why are IBRX shares at highs? The stock has jumped around 55% over the last month, thanks to...
Recent Comments